Aging and HIV infection: focus on cardiovascular disease risk

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Effective antiretroviral therapy has extended life expectancy for individuals with HIV. Estimates from 2015 indicate that 47% of persons with HIV in the US were older than 50 years of age and 16% were older than 65 years. These older patients are at increased risk of age-related diseases and conditions. Further, there is substantial evidence that patients with HIV infection accumulate age-related conditions earlier than do those in the general population. There is risk for increased comorbidities and polypharmacy in the aging HIV-infected population. Specific measures for assessing and reducing the risk of cardiovascular disease and other age-related conditions in the aging HIV population are needed. This article summarizes a presentation by Judith A. Aberg, MD, at the International Antiviral Society-USA (IAS-USA) annual continuing education program held in Chicago, Illinois, in May 2019.

Original languageEnglish
Pages (from-to)102-105
Number of pages4
JournalTopics in antiviral medicine
Issue number4
StatePublished - 1 Jan 2020


Dive into the research topics of 'Aging and HIV infection: focus on cardiovascular disease risk'. Together they form a unique fingerprint.

Cite this